Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
44.95
-2.05 (-4.36%)
At close: Nov 20, 2025, 4:00 PM EST
44.56
-0.39 (-0.87%)
After-hours: Nov 20, 2025, 6:19 PM EST

Soleno Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Selling, General & Admin
128.55105.8613.489.8410.818.76
Upgrade
Research & Development
52.5678.5725.1915.2721.4523.19
Upgrade
Operating Expenses
181.11184.4338.6725.1132.2631.95
Upgrade
Operating Income
-84.27-184.43-38.67-25.11-32.26-31.95
Upgrade
Interest Expense
-4.36-0.23----
Upgrade
Interest & Investment Income
15.1912.052.580.30.110.01
Upgrade
Other Non Operating Income (Expenses)
---0.180.030.5111.64
Upgrade
EBT Excluding Unusual Items
-73.44-172.61-36.27-24.78-31.64-20.3
Upgrade
Other Unusual Items
-5.01-3.24-2.710.710.73-4.34
Upgrade
Pretax Income
-78.45-175.85-38.99-24.07-30.91-24.64
Upgrade
Earnings From Continuing Operations
-78.45-175.85-38.99-24.07-30.91-24.64
Upgrade
Net Income
-78.45-175.85-38.99-24.07-30.91-24.64
Upgrade
Net Income to Common
-78.45-175.85-38.99-24.07-30.91-24.64
Upgrade
Shares Outstanding (Basic)
494016854
Upgrade
Shares Outstanding (Diluted)
494016854
Upgrade
Shares Change (YoY)
28.16%143.61%96.40%57.90%27.39%83.41%
Upgrade
EPS (Basic)
-1.62-4.38-2.36-2.87-5.81-5.90
Upgrade
EPS (Diluted)
-1.62-4.38-2.36-2.87-5.81-5.90
Upgrade
Free Cash Flow
-25.92-69.31-24.94-20.79-27.79-25.23
Upgrade
Free Cash Flow Per Share
-0.53-1.73-1.51-2.48-5.23-6.04
Upgrade
EBITDA
-82.26-182.44-36.71-23.15-30.3-30
Upgrade
D&A For EBITDA
2.011.991.961.961.961.95
Upgrade
EBIT
-84.27-184.43-38.67-25.11-32.26-31.95
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q